In fact, HIF-1 is a master regulator of cellular responses to hypoxia, and it can directly bind to the third intron of the SLC7A11 gene to activate its transcription after exposure to paclitaxel, a chemotherapy drug, in breast cancer cells [45]. This evidence concerns the gene SLC7A11 and breast carcinoma.